| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| So | Jim Cramer on BillionToOne: "I Say Buy It" | 1 | Insider Monkey | ||
| 13.05. | Guggenheim raises BillionToOne stock price target to $120 on reimbursement progress | 2 | Investing.com | ||
| 12.05. | BillionToOne mit Gewinnsprung in Q1 2026: Aktie steigt nach starken Zahlen deutlich | 1 | Investing.com Deutsch | ||
| 08.05. | Wall Street Analysts Predict a 25.63% Upside in BillionToOne (BLLN): Here's What You Should Know | 3 | Zacks | ||
| 07.05. | BillionToOne Q1 2026 slides: 84% revenue surge, 73% gross margin | 1 | Investing.com | ||
| 06.05. | BillionToOne: Umsatz im ersten Quartal 2026 steigt um 84 % | 2 | Investing.com Deutsch | ||
| 06.05. | BillionToOne, Inc. GAAP EPS of $0.34 beats by $0.30, revenue of $108.39M beats by $11.09M | 1 | Seeking Alpha | ||
| 06.05. | BillionToOne, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| BILLIONTOONE Aktie jetzt für 0€ handeln | |||||
| 06.05. | BillionToOne, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 04.05. | What Makes BillionToOne (BLLN) a Revolutionizer in Genetic Testing? | 4 | Insider Monkey | ||
| 15.04. | BillionToOne, Inc.: BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026 | 2 | GlobeNewswire (USA) | ||
| 02.04. | BillionToOne Shares Slip 4% On Oncology Leadership Appointment | 2 | RTTNews | ||
| 02.04. | BillionToOne ernennt Allen Chen zum Vice President für Onkologie | 1 | Investing.com Deutsch | ||
| 16.03. | Piper Sandler reiterates BillionToOne stock rating on NIPT tech | 3 | Investing.com | ||
| 05.03. | BTIG lowers BillionToOne stock price target on valuation multiples | 1 | Investing.com | ||
| 05.03. | BillionToOne Swings To Profit In Q4; Lifts FY26 Guidance | 2 | RTTNews | ||
| 05.03. | BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge | 3 | Investing.com | ||
| 04.03. | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | 1.292 | GlobeNewswire (Europe) | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| 04.03. | BillionToOne, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 17.02. | BillionToOne, Inc.: BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 | 2 | GlobeNewswire (USA) |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VIROMED MEDICAL | 6,800 | -1,45 % | EQS-DD: Viromed Medical AG: Uwe Perbandt, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
13.05.2026 / 18:00... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,39 | +1,18 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,540 | +1,10 % | Alignment Healthcare USA, LLC: Alignment Health Plan Recognized as One of Four Medicare Advantage Prescription Drug Plans in the U.S. for 2026 Excellence in Quality | ||
| PROCEPT BIOROBOTICS | 25,690 | -0,85 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| CO-DIAGNOSTICS | 2,020 | +2,54 % | Co-Diagnostics Reports First Quarter 2026 Financial Results | Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion
Executing Clinical Strategy with Upper Respiratory Submission Preparation... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 33,790 | -0,53 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Siemens Healthineers von 60 auf 50 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Mit der Sparte Bildgebende Verfahren... ► Artikel lesen | |
| HEARTFLOW | 26,640 | +0,15 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,970 | -1,37 % | Privia Health im ersten Quartal 2026: Umsatz schlägt Prognosen, Gewinn pro Aktie enttäuscht deutlich | ||
| PROGYNY | 24,600 | 0,00 % | Canaccord upgrades Progyny stock rating to buy on guidance beat streak | ||
| ADAPTHEALTH | 10,350 | 0,00 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
| GENEDX | 41,660 | -1,12 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| FRESENIUS | 39,760 | +0,18 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
15.05.2026 /... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 7,760 | +1,70 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance | First Quarter Revenue was $647.9 million, a 15.9% increase over the prior year periodFirst Quarter Net income was $41.7 million compared to $5.2 million for the prior year periodAdjusted EBITDA for... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,230 | -0,60 % | Shortseller-Positionen aktuell: u.a. Evotec, FMC, Gerresheimer, Hypoport, Nagarro, Nordex, Suss MicroTec | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| LUMEXA IMAGING | 6,960 | -0,57 % | Lumexa Imaging Adds Four New Imaging Centers As It Expands Across The Southeast And Mid-Atlantic |